Search filters

List of works by Jianxiang Wang

2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies

scientific article published on 16 May 2019

A novel fusion protein TBLR1-RARα acts as an oncogene to induce murine promyelocytic leukemia: identification and treatment strategies

scientific article published on 11 June 2021

Antibody Inhibition of Properdin Prevents Complement-Mediated Intravascular and Extravascular Hemolysis

scientific article published on 13 June 2018

Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN randomized study

scientific article published on 07 April 2020

Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia

scientific article published on 07 September 2020

Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase 3, Randomized, Open-label, Multi-center FESTnd Study

scientific article published on 14 September 2020

Mutant U2AF1-induced differential alternative splicing causes an oxidative stress in bone marrow stromal cells

scientific article published on 25 May 2021

Risk of hepatitis B reactivation is controllable in patients with B-cell lymphoma receiving anti-CD19 CAR T cell therapy

scientific article published on 15 July 2020

TARGET: a survey of real-world management of chronic myeloid leukaemia across 33 countries

scientific article published on 30 March 2020

c-MPL Is a Candidate Surface Marker and Confers Self-Renewal, Quiescence, Chemotherapy Resistance, and Leukemia Initiation Potential in Leukemia Stem Cells

scientific article published on 05 September 2018

Paulina is supported by:

About Paulina

Help